This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

ChinaBio® Partnering Forum

Event begins in:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
Kerry Hotel Pudong
April 23–24, 2025 | Shanghai, ChinaApril 29–30, 2025 | Virtual
Book Now
Menu
Book Now

Sophie Guo
BD Manager at Nanjing Chia-Tai Tianqing Pharmaceutical Company
Presenter

Profile

Nanjing Chia-Tai Tianqing Pharmaceutical Company, or NJCTTQ for short, was jointly founded by CP Group, a Thai company and Jiangsu Nongken Group. NJCTTQ specializes in research and development, production and commercialization of drugs for cardiovascular diseases, renal diseases, tumors, perioperative care, gastrointestinal disorders and urologic diseases. The company now ranks high among China’s top 100 pharmaceutical companies.

Agenda Sessions

  • Renal: Nanjing Chia-Tai Tianqing Pharmaceutical Company

    , 11:00
    View Session

At this event

Prev
Next
Vincent (Qifeng) Han
Global BD&L Associate Director
Boehringer Ingelheim Human Pharma

See Sophie at ChinaBio® Partnering Forum

Book Now